Hyperlipidaemia. Hyperlipidaemia, unspecified
Conditions
Interventions
Intervention 1: In the intervention group, patients with Hyperlipidemia will receive 2 tablet of L - Carnitine (each tablet 1g) for eight weeks. Intervention 2: In the control group, patients with Hyp
Treatment - Drugs
In the intervention group, patients with Hyperlipidemia will receive 2 tablet of L - Carnitine (each tablet 1g) for eight weeks.
In the control group, patients with Hyperlipidemia will receive 2 tablet of placebo (each tablet 1g) for eight weeks.
Sponsors
Vice chancellor for research, Baqiyatallah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Incidence of Hyperlipidemia with Cholesterol levels = 200 mg /dL or Triglycerides levels = 200 mg /dL) or LDL = 130; Age range between 18 and 65 years; Both groups of males and females; Patients do not use Hypolipidemia drugs in 2 month ago. Exclusion criteria: Hypothyroidism disease; Acute Coronary Disease; Renal disease; Pregnancy; Usage of drugs and alcohol; Inflammatory disease; Chronic Liver Disease (Cirrhosis, Hepatitis, etc.); Anti-seizure drugs; Consumption of antioxidant supplements.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total Antioxidant Capacity. Timepoint: Before and after Intervention. Method of measurement: ELISA.;Serum Malondialdehyde. Timepoint: Before and after Intervention. Method of measurement: Colorimetric.;GSH. Timepoint: Before and after Intervention. Method of measurement: Colorimetric. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHesam Kazemzad
Baqiyatallah University of Medical Science
Outcome results
None listed